Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal

By Dilasha Seth

  • 09 May 2024
Premium
Khaldoon Khalifa Al-Mubarak, managing director and group CEO, Mubadala

Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.